Trial · NCT04810091
Adverse events64
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 64
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hyperglycemia | Metabolism and nutrition disorders | Placebo + SSA | 11 | 35 | 13 |
| other | Hyperglycemia | Metabolism and nutrition disorders | Xermelo + SSA | 20 | 32 | 21 |
| other | Nausea | Gastrointestinal disorders | Placebo + SSA | 6 | 35 | 11 |
| other | Nausea | Gastrointestinal disorders | Xermelo + SSA | 7 | 32 | 8 |
| other | Constipation | Gastrointestinal disorders | Placebo + SSA | 5 | 35 | 6 |
| other | Constipation | Gastrointestinal disorders | Xermelo + SSA | 8 | 32 | 8 |
| other | Alkaline phosphtase increased | Investigations | Placebo + SSA | 3 | 35 | 4 |
| other | Alkaline phosphtase increased | Investigations | Xermelo + SSA | 8 | 32 | 8 |
| other | Fatigue | General disorders | Placebo + SSA | 4 | 35 | 6 |
| other | Fatigue | General disorders | Xermelo + SSA | 5 | 32 | 5 |
| other | Headache | Nervous system disorders | Placebo + SSA | 4 | 35 | 5 |
| other | Headache | Nervous system disorders | Xermelo + SSA | 6 | 32 | 6 |
| other | Anemia | Blood and lymphatic system disorders | Placebo + SSA | 4 | 35 | 4 |
| other | Anemia | Blood and lymphatic system disorders | Xermelo + SSA | 5 | 32 | 5 |
| other | Creatinine increased | Renal and urinary disorders | Placebo + SSA | 8 | 35 | 8 |
| other | Creatinine increased | Renal and urinary disorders | Xermelo + SSA | 1 | 32 | 1 |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Placebo + SSA | 5 | 35 | 5 |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Xermelo + SSA | 3 | 32 | 3 |
| other | Heart failure | Cardiac disorders | Placebo + SSA | 1 | 35 | 1 |
| other | Heart failure | Cardiac disorders | Xermelo + SSA | 7 | 32 | 7 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04810091/events